Search
MSK researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a potential therapeutic target in cancer.
Advances in our understanding of the biology of breast cancer are guiding the development of individualized treatment plans. We outline the clinical case history of young breast cancer patient, Elizabeth Shelley, including our rational for not proceeding with the originally prescribed chemotherapy.
Research confirms a sound strategy for designing a therapeutic vaccine for pancreatic cancer.
A team of experts at Memorial Sloan Kettering shared their insights on gynecologic cancer and women’s health in an Information Session for patients, caregivers and those at increased risk for the diseases.
New MSK research investigates whether introducing new mutations could make immunotherapy more effective against some cancers; shows that people in their 90s who underwent lung cancer surgery had positive outcomes; shares lessons on the responsible governance of artificial intelligence in oncology; studies AI-assisted biomarker assessment in lung cancer; and demonstrates a cancer-trained large language model has strong predictive value.
Early-onset colorectal cancer (CRC) is likely clinically and genomically indistinguishable from average-onset cancer, according to a recent study published in the Journal of the National Cancer Institute by MSK investigators.
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors.
People with prostate cancer can benefit from exercise in more ways than they might expect.
Learn how Dr. Chrysothemis Brown is shedding light on new types of immune cells and their role in cancer and other diseases.